AXGN
AxoGen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$48.28
+2.51%Forward multiples
Based on analyst estimates
- P/E forward
- 83.18x
- P/E 2026E
- 106.09x
- P/E 2027E
- 69.31x
- P/E 2028E
- 49.03x
- P/S forward
- 8.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.13x
- Price / sales
- 10.33x
- Price / cash flow
- 278.50x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 10.04x
- EV / EBITDA
- -170.68x
- EV / EBIT
- -196.23x
- Market cap
- $2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026